William Quinn
Director of Finance/CFO chez BOLT BIOTHERAPEUTICS, INC.
Fortune : 41 350 $ au 29/02/2024
Profil
William P.
Quinn founded Bullet Biotechnology, Inc. Presently, Mr. Quinn is Chief Financial Officer of Bolt Biotherapeutics, Inc. He is also on the board of Neurogastrx, Inc., Solar Roof Dynamics LLC and A Foundation Building Strength For Nemaline Myopathy.
Mr. Quinn previously occupied the position of President, Chief Executive Officer & Director at Bullet Biotechnology, Inc., Chief Financial & Operating Officer at Novation Biosciences, Inc., CFO & Principal Accounting Officer of Sunesis Pharmaceuticals, Inc. and Head-Corporate Development at Jazz Pharmaceuticals, Inc.
William P.
Quinn received an MBA from Stanford Graduate School of Business and an undergraduate degree and a graduate degree from Stanford University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
04/03/2024 | 36 272 ( 0,10% ) | 41 350 $ | 29/02/2024 |
Postes actifs de William Quinn
Sociétés | Poste | Début |
---|---|---|
BOLT BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 01/05/2020 |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Director/Board Member | - |
Solar Roof Dynamics LLC | Director/Board Member | 01/11/2017 |
A Foundation Building Strength For Nemaline Myopathy | Director/Board Member | 01/03/2011 |
Anciens postes connus de William Quinn
Sociétés | Poste | Fin |
---|---|---|
VIRACTA THERAPEUTICS, INC. | Director of Finance/CFO | 01/05/2020 |
Midnight Pharmaceuticals, Inc.
Midnight Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Midnight Pharmaceuticals, Inc. develops novel products for the treatment of insomnia. The CEO of the American company is Jed Black. | Director/Board Member | 01/02/2019 |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Founder | 01/11/2017 |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01/06/2011 |
Novation Biosciences, Inc. | Director of Finance/CFO | 01/12/2002 |
Formation de William Quinn
Stanford University | Graduate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 9 |
---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Health Technology |
Novation Biosciences, Inc. | |
Bolt Biotherapeutics, Inc. | |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
Solar Roof Dynamics LLC | |
Midnight Pharmaceuticals, Inc.
Midnight Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Midnight Pharmaceuticals, Inc. develops novel products for the treatment of insomnia. The CEO of the American company is Jed Black. | Health Technology |
A Foundation Building Strength For Nemaline Myopathy |